The Allstate Corporation $ALL is Nebula Research & Development LLC’s Largest Position

Nebula Research & Development LLC increased its position in The Allstate Corporation (NYSE:ALL) by 229.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,018 shares of the insurance provider’s stock after buying an additional 18,123 shares during the quarter. Allstate comprises about 0.4% of Nebula Research & Development LLC’s investment portfolio, making the stock its biggest position. Nebula Research & Development LLC’s holdings in Allstate were worth $5,238,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Guerra Pan Advisors LLC lifted its stake in shares of Allstate by 1.5% in the 2nd quarter. Guerra Pan Advisors LLC now owns 3,426 shares of the insurance provider’s stock valued at $690,000 after purchasing an additional 49 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in shares of Allstate by 4.7% during the second quarter. Parkside Financial Bank & Trust now owns 1,189 shares of the insurance provider’s stock worth $239,000 after purchasing an additional 53 shares in the last quarter. L2 Asset Management LLC grew its stake in shares of Allstate by 4.8% in the second quarter. L2 Asset Management LLC now owns 1,168 shares of the insurance provider’s stock valued at $235,000 after buying an additional 53 shares in the last quarter. Ancora Advisors LLC grew its stake in shares of Allstate by 0.7% in the first quarter. Ancora Advisors LLC now owns 8,402 shares of the insurance provider’s stock valued at $1,740,000 after buying an additional 55 shares in the last quarter. Finally, Cooper Financial Group raised its holdings in shares of Allstate by 5.5% during the 2nd quarter. Cooper Financial Group now owns 1,057 shares of the insurance provider’s stock valued at $213,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling

In related news, insider Suren Gupta sold 21,871 shares of the company’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $215.21, for a total transaction of $4,706,857.91. Following the completion of the transaction, the insider directly owned 100,646 shares in the company, valued at $21,660,025.66. This represents a 17.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders sold 28,807 shares of company stock worth $6,198,726. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

ALL has been the subject of several recent research reports. Citigroup raised shares of Allstate to a “hold” rating in a research report on Wednesday, August 13th. BMO Capital Markets raised their price target on shares of Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Wells Fargo & Company lifted their price target on shares of Allstate from $202.00 to $216.00 and gave the stock an “equal weight” rating in a research note on Friday, November 7th. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a report on Wednesday, October 8th. Finally, Roth Capital lifted their price objective on Allstate from $230.00 to $240.00 and gave the stock a “buy” rating in a report on Wednesday, November 26th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $237.92.

Allstate Trading Up 0.0%

NYSE ALL opened at $201.13 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.43 and a current ratio of 0.43. The Allstate Corporation has a one year low of $176.00 and a one year high of $215.89. The company has a 50-day simple moving average of $203.80 and a 200-day simple moving average of $202.40. The firm has a market capitalization of $52.63 billion, a PE ratio of 6.51, a price-to-earnings-growth ratio of 0.38 and a beta of 0.25.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 12.53% and a return on equity of 35.42%. The firm had revenue of $17.26 billion for the quarter, compared to analysts’ expectations of $16.59 billion. During the same quarter last year, the company posted $3.91 earnings per share. Allstate’s revenue was up 3.8% on a year-over-year basis. On average, equities analysts forecast that The Allstate Corporation will post 18.74 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 1st will be given a dividend of $1.00 per share. The ex-dividend date is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a yield of 2.0%. Allstate’s payout ratio is currently 12.95%.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.